Open Access
Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort
Author(s) -
E. David Crawford
Publication year - 2011
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s12700
Subject(s) - leuprorelin , triptorelin , medicine , agonist , prostate cancer , testosterone (patch) , adverse effect , gonadotropin releasing hormone agonist , gonadotropin releasing hormone , oncology , urology , hormone , gynecology , cancer , luteinizing hormone , receptor